{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:10:22Z","timestamp":1770754222711,"version":"3.50.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Institut de Recerca de l\u2019Hospital de la Santa Creu i Sant Pau-IIB Sant Pau"},{"name":"RB Pharmaceuticals Ltd."},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.drugalcdep.2020.108010","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T07:02:09Z","timestamp":1587970929000},"page":"108010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxone"],"prefix":"10.1016","volume":"212","author":[{"given":"Jos\u00e9","family":"P\u00e9rez de los Cobos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Si\u00f1ol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Gonz\u00e1lez-Saiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza","family":"Vergara-Moragues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Trujols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108010_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2018.02.020","article-title":"A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers","volume":"187","author":"Alcaraz","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0020","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2004-0929","article-title":"Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence","volume":"90","author":"Bliesener","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.2044-8317.1972.tb00492.x","article-title":"Oblique rotation to a partially specified target","volume":"25","author":"Browne","year":"1972","journal-title":"Br. J. Math. Stat. Psychol."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2017.10.035","article-title":"Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine\/naloxone maintenance treatment","volume":"183","author":"Gonz\u00e1lez-Saiz","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1743-6109.2007.00702.x","article-title":"Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment","volume":"5","author":"Hallinan","year":"2008","journal-title":"J. Sex Med."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0045","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025799","article-title":"Slow release oral morphine versus methadone for the treatment of opioid use disorder","volume":"9","author":"Klimas","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0146621613487794","article-title":"Factor 9.2: A comprehensive program for fitting exploratory and semiconfirmatory factor analysis and IRT models","volume":"37","author":"Lorenzo-Seva","year":"2013","journal-title":"Appl. Psychol. Meas."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1027\/1614-2241.2.2.57","article-title":"Tucker\u2019s congruence coefficient as a meaningful index of factor similarity","volume":"2","author":"Lorenzo-Seva","year":"2006","journal-title":"Methodology (Gott.)"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.6018\/analesps.32.2.215161","article-title":"Multiple Imputation of missing values in exploratory factor analysis of multidimensional scales: Estimating latent trait scores","volume":"32","author":"Lorenzo-Seva","year":"2016","journal-title":"An. Psicol."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"13","author":"Minozzi","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2019.03.012","article-title":"Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods","volume":"101","author":"Oviedo-Joekes","year":"2019","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugpo.2018.06.007","article-title":"Development and validation of the scale to assess satisfaction with medications for addiction treatment - Buprenorphine-naloxone for heroin addiction (SASMAT-BUNHER)","volume":"58","author":"P\u00e9rez de los Cobos","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2014.05.024","article-title":"Development and validation of the scale to assess satisfaction with medications for addiction treatment-methadone for heroin addiction (SASMAT-METHER)","volume":"142","author":"P\u00e9rez de los Cobos","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","article-title":"Pharmacological and behavioral treatment of opioid use disorder","volume":"1","author":"Sofuoglu","year":"2019","journal-title":"Psych. Res. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/JCP.0b013e3182401e09","article-title":"Satisfaction with methadone as a medication. Psychometric properties of the Spanish version of the treatment satisfaction questionnaire for medication","volume":"32","author":"Trujols","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0100","series-title":"A method for synthesis of factor analysis studies (Personnel Research Section Report No. 984)","author":"Tucker","year":"1951"},{"key":"10.1016\/j.drugalcdep.2020.108010_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147852","article-title":"Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment","volume":"11","author":"Yee","year":"2016","journal-title":"PLoS One"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620301757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620301757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:02:33Z","timestamp":1759827753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620301757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":21,"alternative-id":["S0376871620301757"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108010","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxone","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108010"}}